In line with this, we have shown previously that the anti-diabetic drug metformin is capable of dephosphorylating tau at AD-relevant phospho-sites by interfering with the assembly of the MID1-PP2A-complex7. This evidence concerns the gene PTPA and Alzheimer disease.